Results of treatment with CMA, a low intermediate regimen, in endemic Burkitt lymphomas in sub-Saharian Africa: Experience of Côte d'Ivoire

International Journal of Hematology

Volumn 91, Issue 5, 2010, Pages 838-843

  Koffi, Gustave Kouassi ^a   Tolo, Aissata ^a   Nanho, Danho Clotaire ^a   N'Dathz, Emeraude ^a   Kouassi, Mathias Yao ^a   N'Diaye, Fatou Diago ^a   Kouakou, Boidy ^a   Meité, N'Dogomo ^a   Ayemou, Romeo ^a   Sekongo, Mamadou ^a   Kouehion, Paul ^a   Meité, Mori ^a   Tea, Norbert Dagnekpo ^a   Sangaré, Amadou ^a   Sanogo, Ibrahima ^a  

^a Hematology National Teaching Hospital   (Côte d’Ivoire)

Author keywords

Burkitt lymphoma; CMA chemotherapy; Low intermediate therapy

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; METHOTREXATE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BONE MARROW METASTASIS; BURKITT LYMPHOMA; CANCER GROWTH; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; COTE D'IVOIRE; CYTOPENIA; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PANCYTOPENIA; PRESCHOOL CHILD; SCHOOL CHILD; THROMBOCYTOPENIA; TREATMENT RESPONSE; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; COTE D'IVOIRE; CYCLOPHOSPHAMIDE; CYTARABINE; FEMALE; HUMANS; MALE; METHOTREXATE; TREATMENT OUTCOME;

EID: 77954540907     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0591-z     Document Type: Article

References (18)

1. D Burkitt 1958 A sarcoma involving the jaws in African children Br J Surg 46 218 10.1002/bjs.18004619704 1:STN:280:DyaG1M%2FlvVGkuw%3D%3D 13628987
2. Burkitt DP. General features and facial tumours. In: Burkitt DP, Wright DH, editors. Burkitt's lymphoma. Edinburgh: E&S Livingstone; 1970. p. 64.
3. Magrath IT, Sariban E. Clinical features of Burkitt's lymphoma in the USA. In: Lenoir G, O'Conor G, Olweny CLM, editors. Burkitt's lymphoma: a human cancer model, no. 60. Lyon, France: IARC Scientific; 1985. p. 119.
4. G Mead M Sydes J Walewski, et al. 2002 An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study Ann Oncol 13 1264 1274 10.1093/annonc/mdf253 1:STN:280:DC%2BD38visVeqtQ%3D%3D 12181251 (Pubitemid 34960136)
5. F Spreafico M Massimino R Luksch, et al. 2002 Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children J Clin Oncol 20 2783 2788 10.1200/JCO.2002.08.088 1:CAS:528:DC%2BD38Xlt1KitL0%3D 12065554 (Pubitemid 34651506)
6. Koffi KG, Bosson NM, Aka-adjo MN, Diop S, N'Dhatz E, Ahmedou O, Sanogo I, Sangaré A. Results on the treatment of the African Burkitt lymphoma in Abidjan Côte d'Ivoire. Médecine d'Afrique Noire. 1997;44(12):635-9.
7. N Harris E Jaffe J Diebold, et al. 1999 World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997 J Clin Oncol 7 3835 3849
8. N'Krumah FK, Katongole ME. Long term experience with Burkitt's lymphoma: the African experience, no. 60. IARC Scientific Publications; 1985. p. 375-82.
9. DP Burkitt GT O'Conor 1991 Malignant lymphoma in African children Cancer 14 258 10.1002/1097-0142(196103/04)14:2<258::AID-CNCR2820140206>3.0.CO;2-7
10. CL Olweny ME Katongole D Otim SK Lwanga IT Magrath JL Ziegler 1980 Long term experience with Burkitt's lymphoma in Uganda Int J Cancer 26 3 261 266 10.1002/ijc.2910260302 1:STN:280:DyaL38%2FivFOhtg%3D%3D 7287207 (Pubitemid 10049393)
11. OCK Williams AO Folami O Seriki 1983 Patterns of treatment failure in Burkitt's lymphoma Eur J Cancer Clin Oncol 19 6 741 746 10.1016/0277-5379(83) 90007-X 1:STN:280:DyaL3s3mt1Siuw%3D%3D 6683647
12. Ben AF, Boussen H, Jaafoura M, Ben YR, Marouene A, Trabelsi N, Tabbane F, Cammoun M, Mouralli N. Burkitt's lymphoma in Tunisia. Study of 18 cases. Tunisie médicale. 1984;62(1):73-7.
13. C Soussain C Patte M Ostronoff, et al. 1995 Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols Blood 85 664 674 1:CAS:528:DyaK2MXjtlCqtLo%3D 7833470
14. Smeland S, Blystad AK, Kvaløy SO, et al. Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens. Ann Oncol. 2004;15(7):1072-8.
15. Divine M, Cassasus P, Koscielny S, et al. Adult Burkitt lymphoma. A prospective multicenter trial with the LMB protocol. Proc Am Soc Clin Oncol. 2000;19:80.
16. S Murphy W Bowman M Abromowitch, et al. 1986 Results of treatment of advanced-stage Burkitt's lymphoma and B cell (S Ig+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine J Clin Oncol 4 1732 1739 1:STN:280: DyaL2s%2FlvF2nuw%3D%3D 3491184
17. C Patte T Philip C Rodary, et al. 1991 High survival rate in advanced-stage B-cell lymphomas and leukaemia's without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children J Clin Oncol 9 123 132 1:STN:280:DyaK3M%2Fos12nug%3D%3D 1985161
18. M Schwenn S Blattner E Lynch H Weinstein 1991 HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia J Clin Oncol 9 133 138 1:STN:280:DyaK3M%2Fos12nuw%3D%3D 1985162